Few differences were observed in immune cell subset fractions when comparisons were restricted to patients and controls who did not use DEX, or glioma patients who used DEX; in DEX users, CD8 T and B cell fractions, and LMR were lower in IDHwt compared to IDHmt GBM patients (Fig. 4). The gene discussed is CD8A; the disease is central nervous system cancer.